We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+9.48%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$34.5B
AUM Growth
+$1.76B
(+5.4%)
Cap. Flow
-$769M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
26.77%
Holding
1,963
New
176
Increased
1,051
Reduced
620
Closed
112
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Albemarle
ALB
|
+$68.7M |
| 2 |
GE HealthCare
GEHC
|
+$28.6M |
| 3 |
ON Semiconductor
ON
|
+$28.1M |
| 4 |
Caterpillar
CAT
|
+$22.6M |
| 5 |
IBM
IBM
|
+$20.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$94.9M |
| 2 |
Apple
AAPL
|
+$91M |
| 3 |
West Pharmaceutical
WST
|
+$69M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$61.8M |
| 5 |
Amazon
AMZN
|
+$55.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Industrials | 12.05% |
| 3 | Consumer Staples | 10.74% |
| 4 | Consumer Discretionary | 10.51% |
| 5 | Healthcare | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VLD
1826
DELISTED
Velo3D, Inc.
VLD
| $25K | ﹤0.01% |
+331
| New | +$23.1K |
|
1827
Outdoor Holding Co
POWW
$244M
| $25K | ﹤0.01% |
11,732
+1,319
| +13% | +$2.58K |
|
|
KG
1828
Kestrel Group
KG
$71.2M
| $24.8K | ﹤0.01% |
+590
| New | +$25.2K |
|
1829
Lineage Cell Therapeutics
LCTX
$267M
| $23.7K | ﹤0.01% |
+16,784
| New | +$23.2K |
|
1830
Douglas Elliman
DOUG
$155M
| $23.4K | ﹤0.01% |
10,545
-730
| -6% | -$2K |
|
1831
Kaltura
KLTR
$206M
| $22.9K | ﹤0.01% |
+10,796
| New | +$20K |
|
1832
Microvast
MVST
$287M
| $21.9K | ﹤0.01% |
13,672
-6,622
| -33% | -$9.44K |
|
|
OPTN
1833
DELISTED
OptiNose
OPTN
| $20.6K | ﹤0.01% |
+1,115
| New | +$26.4K |
|
|
TIO
1834
DELISTED
Tingo Group, Inc. Common Stock
TIO
| $19.2K | ﹤0.01% |
+15,883
| New | +$35.8K |
|
1835
Citius Pharmaceuticals
CTXR
$14.6M
| $19.2K | ﹤0.01% |
+639
| New | +$21K |
|
1836
BARK
BARK
$77.3M
| $18.9K | ﹤0.01% |
712
+74
| +12% | +$1.78K |
|
1837
Workhorse Group
WKHS
$30.1M
| $18.8K | ﹤0.01% |
7
+1
| +17% | +$2.89K |
|
1838
AtaiBeckley Inc
ATAI
$2.65B
| $18.5K | ﹤0.01% |
10,742
-758
| -7% | -$1.4K |
|
1839
ESS Tech
GWH
$23.5M
| $17.4K | ﹤0.01% |
+791
| New | +$14.3K |
|
|
CRGE
1840
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
| $17.2K | ﹤0.01% |
17,520
+2,209
| +14% | +$2.24K |
|
|
LLAP
1841
DELISTED
Terran Orbital Corporation
LLAP
| $16.6K | ﹤0.01% |
+11,084
| New | +$17.5K |
|
1842
Heron Therapeutics
HRTX
$86.9M
| $15.6K | ﹤0.01% |
13,467
+1,355
| +11% | +$2.42K |
|
1843
Smartbird Inc
BIRD
$22.5M
| $15.6K | ﹤0.01% |
618
+50
| +9% | +$1.25K |
|
|
AEVA
1844
Aeva Technologies
AEVA
$1.1B
| $12.9K | ﹤0.01% |
2,067
-213
| -9% | -$1.22K |
|
1845
Skillsoft
SKIL
$55.8M
| $12.9K | ﹤0.01% |
+521
| New | +$15.2K |
|
1846
Alaunos Therapeutics
TCRT
$4.69M
| $7.94K | ﹤0.01% |
104
-7
| -6% | -$566 |
|
1847
Inovio Pharmaceuticals
INO
$83.9M
| $7.59K | ﹤0.01% |
1,417
-2,449
| -63% | -$19.7K |
|
1848
Nektar Therapeutics
NKTR
$2.34B
| $7.04K | ﹤0.01% |
816
-1,824
| -69% | -$19.4K |
|
|
VRAY
1849
DELISTED
ViewRay, Inc.
VRAY
| $6.85K | ﹤0.01% |
19,456
+2,031
| +12% | +$2.1K |
|
|
ADAP
1850
DELISTED
Adaptimmune Therapeutics
ADAP
| – | – |
-10,077
| Closed | -$11K |
|
Similar funds
ProShare Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, ProShare Advisors held 1,963 positions worth $34.5B, up 5.4% from $32.7B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
ProShare Advisors's Q2 2023 filing shows 176 new, 1,051 increased, 620 reduced and 112 closed positions. Its largest new stake was Artesian Resources: 162,581 shares worth $7.68M. The largest sale was Microsoft, an estimated $94.9M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Consumer Staples.
- ProShare Advisors's largest Q2 2023 buy was Artesian Resources: 162,581 shares worth $7.68M.
- ProShare Advisors added most to Albemarle in Q2 2023, an estimated $68.7M increase.
- ProShare Advisors's biggest Q2 2023 reduction was Microsoft, cutting an estimated $94.9M.
- ProShare Advisors fully exited Rivian in Q2 2023, selling an estimated $11.9M.
- ProShare Advisors's ten largest holdings make up 27% of its $34.5B portfolio in Q2 2023.
- ProShare Advisors opened 176 new positions and closed 112 in Q2 2023.
- ProShare Advisors's portfolio value rose 5.4% quarter-over-quarter to $34.5B.
Based on ProShare Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.